Scienture Holdings Inc
Research Scienture Holdings Inc (SCNX) on Bullrun: market cap USD 6.18M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSCNX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryPharmaceutical Retailers
- CurrencyUSD
- Market capUSD 6.18M
- Financial periodQ2 2026
- RevenueUSD 343.64K
- Net income-USD 2.82M
- Free cash flow-USD 9.18M
- Gross margin97.7%
Valuation Snapshot
latest market cap is USD 6.18M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 431.61K | -USD 41.51M | -USD 13.38M | 76.8% | -2.7 | USD 6.66M | USD 24.14K | USD 70.12M |
| FY2024 | USD 136.64K | USD 9.07M | -USD 14.28M | 4.4% | 2.48 | USD 308.10K | USD 2.90M | USD 79.07M |
| FY2023 | USD 1.36M | -USD 17.84M | -USD 2.23M | 3.6% | -23.35 | USD 361 | USD 209.50K | USD 542.35K |
| FY2022 | USD 10.25M | -USD 3.47M | -USD 1.56M | 53.8% | -6.13 | USD 1.09M | USD 1.58M | USD 763.14K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 6.18M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 20.72M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 52.94M | n/a | 157.0% | 9.5 |
| 2023 | 2023-12-29 | USD 4.26M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 3.76M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 19.27M | n/a | n/a | n/a |
Dividend history
| Year | Dividends/share |
|---|---|
| FY2024 | 9.5 USD |
About Scienture Holdings Inc
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Scienture Holdings Inc's market cap?
Scienture Holdings Inc's market capitalization is USD 6.18M.
What does Scienture Holdings Inc do?
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen.